These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34899733)

  • 1. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.
    Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C
    Front Immunol; 2021; 12():775461. PubMed ID: 34899733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load.
    Jin ZZ; Jin FF; Liu X; Liu N; Wen F; Lou JL
    Braz J Infect Dis; 2019; 23(5):343-351. PubMed ID: 31542378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients].
    Zhang ZH; Peng J; Xia JB; Tian YJ; Jiang M; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):266-70. PubMed ID: 19403024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma.
    Zhang AY; Lai CL; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
    J Gastroenterol; 2017 Sep; 52(9):1064-1074. PubMed ID: 28353014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection.
    Usman Z; Mijočević H; Karimzadeh H; Däumer M; Al-Mathab M; Bazinet M; Frishman D; Vaillant A; Roggendorf M
    J Viral Hepat; 2019 Dec; 26(12):1454-1464. PubMed ID: 31323705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients.
    Hosseini SY; Sanaei N; Fattahi MR; Malek-Hosseini SA; Sarvari J
    Ann Hepatol; 2019; 18(4):640-645. PubMed ID: 31105017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing revealed divergence in deletions of the preS region in the HBV genome between different HBV-related liver diseases.
    Jia J; Liang X; Chen S; Wang H; Li H; Fang M; Bai X; Wang Z; Wang M; Zhu S; Sun F; Gao C
    J Gen Virol; 2017 Nov; 98(11):2748-2758. PubMed ID: 29022863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.
    Bai X; Jia JA; Fang M; Chen S; Liang X; Zhu S; Zhang S; Feng J; Sun F; Gao C
    PLoS Genet; 2018 Feb; 14(2):e1007206. PubMed ID: 29474353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning.
    Chen S; Zhang Z; Wang Y; Fang M; Zhou J; Li Y; Dai E; Feng Z; Wang H; Yang Z; Li Y; Huang X; Jia J; Li S; Huang C; Tong L; Xiao X; He Y; Duan Y; Zhu S; Gao C
    J Infect Dis; 2021 Jun; 223(11):1887-1896. PubMed ID: 33049037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.
    Colson P; Borentain P; Motte A; Henry M; Moal V; Botta-Fridlund D; Tamalet C; Gérolami R
    Virology; 2007 Oct; 367(1):30-40. PubMed ID: 17573090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen.
    Wang YM; Ng WC; Lo SK
    J Gastroenterol; 1999 Oct; 34(5):600-6. PubMed ID: 10535488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies.
    Liu H; Shen L; Zhang S; Wang F; Zhang G; Yin Z; Qiu F; Liang X; Wang F; Bi S
    Virol J; 2020 Jun; 17(1):75. PubMed ID: 32532295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B.
    Liang Y; Yano Y; Putri WA; Mardian Y; Okada R; Tanahashi T; Murakami Y; Hayashi Y
    Mol Med Rep; 2018 Apr; 17(4):5528-5537. PubMed ID: 29393485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination.
    Galati G; De Vincentis A; Vespasiani-Gentilucci U; Gallo P; Vincenti D; Solmone MC; Dell'Unto C; Picardi A
    BMC Gastroenterol; 2014 May; 14():94. PubMed ID: 24885182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of tryptophan-truncated S quasispecies in treatment-naïve chronic hepatitis B patients.
    Dong H; Zhu Y; Shen Y; Xie S; He Y; Lu L
    J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34292864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.